Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Stockholm County Council, Norra Stationsgatan 69, SE-11364 Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Psychiatry Res. 2019 Aug;278:180-187. doi: 10.1016/j.psychres.2019.06.010. Epub 2019 Jun 12.
Twin- and family studies have shown variations in the heritability estimates of bipolar disorder (BPD). The current study uses an updated statistical methodology for heritability estimation in BPD by taking available time of follow-up into account while controlling for co-variates. We identified monozygotic and dizygotic same and different sex twins with BPD (n = 804) or unaffected from BPD (n = 91,604) from the Swedish Twin Register and the National Patient Register. We applied structural equational modeling with inversed probability weighting to estimate the heritability, taking into account censoring and truncation of data. Sex-limitation models were constructed to analyze qualitative or quantitative sex-differences in BPD. Heritability for BPD was 60.4% (95% Confidence Interval: 50.3-70.5) after age, sex, left-hand truncation and censoring of the data was taken into account. A larger proportion of females were affected from BPD (females 62.2%; males 37.8%, p < 0.001), but no sex-difference in BPD heritability was found, nor any sex-specific genetic effects. We demonstrated a robust 60% heritability for BPD with no evidence of sex-specific genetic effects on disease liability.
双生子和家系研究表明双相障碍(BPD)的遗传度估计存在差异。本研究通过考虑随访时间的变化并控制协变量,采用更新的遗传度估计统计方法来研究 BPD。我们从瑞典双胞胎登记处和国家患者登记处中确定了患有 BPD(n=804)或未受 BPD 影响的同性别和异性别单卵双生子和双卵双生子(n=91604)。我们应用结构方程模型和逆概率加权法来估计遗传度,同时考虑到数据的删失和截断。构建了性别限制模型来分析 BPD 中的定性或定量性别差异。考虑到年龄、性别、左手截断和数据删失后,BPD 的遗传度为 60.4%(95%置信区间:50.3-70.5)。更多的女性患有 BPD(女性 62.2%;男性 37.8%,p<0.001),但未发现 BPD 遗传度存在性别差异,也未发现任何性别特异性的遗传效应。我们证明了 BPD 的遗传率高达 60%,且不存在疾病易感性的性别特异性遗传效应的证据。